Through its Clinical and Translational Science Awards (CTSA) Program funding opportunity announcement (FOA), PAR-18-464, NCATS is updating the forms and instructions for application submission, and incorporated modified review criteria that align with the
"Michael G. Kurilla, M.D., Ph.D. as the new Director of the NCATS Division of Clinical Innovation (DCI). Mike’s new role will include leading the CTSA program.
With a $25 million grant from NCATS, the new National Center for Data to Health will be established within the CTSA Program. The new center will help translational scientists discover and share software, data, and other research resources.
Researchers from the University of Rochester Medical Center are studying whether drugs used to keep HIV patients alive could be damaging their brains. Early results from their clinical study, which was partially supported by the CTSA, suggest that these drugs do not pose a threat to the brain - at least in the short-term.
David Goodman, MD MS (Co-PI of the Dartmouth Atlas) and a member of the Dartmouth CTSA Hub, has developed the Atlas Rate Generator (ARG), which offers investigators an easy to use portal for calculating cross-sectional population-based rates of Medicare beneficiary diagnoses and medical care across U.S. health care markets and counties.
The University of Rochester has been awarded $19 million from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health to coordinate a network of more than 50 institutions across the country.